Countering adipose tissue dysfunction could underlie the superiority of telmisartan in the treatment of obesity-related hypertension

BACKGROUND: The prevalence of hypertension and obesity has increased significantly in recent decades. Hypertension and obesity often coexist, and both are associated with increased cardiovascular mortality. Obese hypertensive patients usually require special anti-hypertensive treatment strategy due...

Descripción completa

Detalles Bibliográficos
Autores principales: Naguib, Yahya M., Samaka, Rehab M., Rizk, Mohamed S., Ameen, Omnia, Motawea, Shaimaa M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988926/
https://www.ncbi.nlm.nih.gov/pubmed/33761942
http://dx.doi.org/10.1186/s12933-021-01259-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988926/
https://www.ncbi.nlm.nih.gov/pubmed/33761942
http://dx.doi.org/10.1186/s12933-021-01259-w

Ejemplares similares